Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives

Go back to Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
Theravance, Inc. (NASDAQ: THRX) Delayed: 4.06 --0 (-0%)
Previous Close $4.06    52 Week High $21.16 
Open $0.72    52 Week Low $6.36 
Day High $4.06    P/E N/A 
Day Low $4.06    EPS $-1.53 
Volume 107,542